Sign inJoin waitlistJoin the waitlist

JH

Jason Hou

Associate Professor · Baylor College of Medicine

Credentials: · · · · · ·

History

Baylor College of Medicine
Present

Gastroenterology
2006–2009
Internal Medicine
2003–2006
Feinberg School of Medicine
1999–2003

Research

Dietary intake and risk of developing inflammatory bowel disease: a systematic review of the literature
Systematic review or meta-analysis · The American Journal of Gastroenterology · 2011 · First of 3 authors · Corresponding · 729 citations
Distribution and manifestations of inflammatory bowel disease in Asians, Hispanics, and African Americans: a systematic review
Systematic review or meta-analysis · The American Journal of Gastroenterology · 2009 · First of 3 authors · 166 citations
Diet and inflammatory bowel disease: review of patient-targeted recommendations
Review · Clinical Gastroenterology and Hepatology · 2014 · First of 3 authors · Corresponding · 160 citations

Hashem El-Serag
26 papers
Akbar Waljee
17 papers
Siddharth Singh
10 papers
Corey Siegel
9 papers
Gil Melmed
9 papers
Linda Feagins
8 papers
Rajesh Shah
8 papers · 1 as a fellow
DL
Donald Lum
7 papers
Frank Scott
7 papers
James Lewis
7 papers
Raymond Cross
7 papers
Shirley Cohen-Mekelburg
7 papers

Grants

A Learning Health System Approach to Using Artificial Intelligence Enabled Decision Support (AEDS) for Medication Optimization in Veteran Care: An Immunosuppressants Use Case
Department of Veterans Affairs · I01
PI · Veterans Health Administration
2024–2028
Effectivenes, Safety, and Patient Preferences of Infliximab Biosimilar Medications for Inflammatory Bowel Disease
Department of Veterans Affairs · I01
Contact PI · Michael e Debakey Va Medical Center
2020–2024
Patient-Centered Comparative Effectiveness of Colorectal Cancer Surveillance in IBD
Agency for Healthcare Research and Quality · K08
Contact PI · $766K · Baylor College of Medicine
2015–2020

Clinical trials

A Study of Eltrekibart and Mirikizumab in Adult Patients With Moderately to Severely Active Ulcerative Colitis
Site PI · Recruiting · Phase 2
Eli Lilly and Company
2024–2028
Treat-to-Target of Endoscopic Remission in Patients With IBD in Symptomatic Remission
Site PI · Recruiting
Mayo Clinic
2022–2029
Testing the Impact of Measurement-Based Care on Quality of Life and Disease Management Among Veterans With Inflammatory Bowel Disease
Sub-investigator · Recruiting
VA Office of Research and Development
2026–2029